HER2 activating mutations act as oncogenic drivers in various cancer types. In the clinic,
they can be identified by next generation sequencing (NGS) in either tumor biopsies or …

Renal transplantation is currently the treatment of choice for end-stage kidney disease,
enabling a quality of life superior to dialysis. Despite this, all transplanted patients are at risk …

A large number of neurological disorders can affect renal transplant recipients, potentially
leading to disabling or life-threatening complications. Prevention, early diagnosis and …

Non-invasive technologies to monitor kidney allograft health utilizing high-throughput
assays of blood and urine specimens are emerging out of the research realm and slowly …

Parathyroid allotransplantation is increasingly practiced for patients who have permanent
hypoparathyroidsm. Parathyroid allotransplantation success is varied, and no defined …

In kidney transplantation, minimizing the side effects of the immunosuppressive regimen and
inducing tolerance to allograft are the two main objectives to improve outcome. At present …

Solid organ transplantation is a life‐saving intervention for individuals with end‐stage organ
failure. Despite the effectiveness of immunosuppressive therapy, the risk of graft rejection …

The extant study aimed to explore the influence of two cytokines TNF-α− 308 and IFN-γ+ 874
gene polymorphism on development of renal transplant rejection and to investigate the …

Background: Graft failure resulting from rejection or any other adverse event usually
originates from an aberrant and/or exaggerated immune response and is often catastrophic …

TORREGROSA, José V. et al. Tratamiento eficaz de la arteriolopatía urémica calcificante
con bifosfonatos. Nefrología (Madr.)[online]. 2012, vol. 32, n. 3, pp. 329-334. ISSN 0211 …